Rossari Biotech Ltd | Industry : (Chemicals) | |
---|---|---|
BSE Code : 543213 |
NSE Symbol : ROSSARI |
P/E(TTM) : 42.85 |
ISIN Demat : INE02A801020 |
Div & Yield% : 0.06 |
EPS(TTM) : 18.69 |
Book Value(₹) : 182.76 |
Market Cap(₹Cr) : 4,433.76 |
Face Value(₹) : 2.00 |
Particulars | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|---|---|
Gross Sales | 368.28 | 335.99 | 300.71 | 313.80 | 298.75 | 332.01 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 368.28 | 335.99 | 300.71 | 313.80 | 298.75 | 332.01 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 1.01 | 1.08 | 1.26 | 1.34 | 2.13 | 1.96 |
Total Income | 369.28 | 337.07 | 301.97 | 315.15 | 300.88 | 333.98 |
Total Expenditure | 318.32 | 291.72 | 260.90 | 272.08 | 257.61 | 289.67 |
PBIDT | 50.97 | 45.35 | 41.06 | 43.06 | 43.27 | 44.30 |
Interest | 2.28 | 1.90 | 2.33 | 1.74 | 2.63 | 2.54 |
PBDT | 48.69 | 43.45 | 38.74 | 41.33 | 40.64 | 41.76 |
Depreciation | 7.43 | 6.54 | 6.06 | 6.58 | 5.84 | 6.26 |
Tax | 11.47 | 9.84 | 8.53 | 8.41 | 10.32 | 9.58 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -0.84 | -0.34 | -0.18 | 0.17 | -1.06 | -0.46 |
Reported Profit After Tax | 30.63 | 27.42 | 24.33 | 26.17 | 25.54 | 26.38 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 30.63 | 27.42 | 24.33 | 26.17 | 25.54 | 26.38 |
EPS (Unit Curr.) | 5.53 | 4.96 | 4.40 | 4.74 | 4.62 | 4.78 |
EPS (Adj) (Unit Curr.) | 5.53 | 4.96 | 4.40 | 4.74 | 4.62 | 4.78 |
Calculated EPS (Unit Curr.) | 5.53 | 4.96 | 4.40 | 4.74 | 4.62 | 4.78 |
Calculated EPS (Adj) (Unit Curr.) | 5.53 | 4.96 | 4.40 | 4.74 | 4.62 | 4.78 |
Calculated EPS (Ann.) (Unit Curr.) | 22.13 | 19.84 | 17.61 | 18.95 | 18.50 | 19.11 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 22.13 | 19.84 | 17.61 | 18.95 | 18.50 | 19.11 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 11.07 | 11.06 | 11.05 | 11.05 | 11.05 | 11.05 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 13.84 | 13.50 | 13.65 | 13.72 | 14.48 | 13.34 |
PBDTM(%) | 13.22 | 12.93 | 12.88 | 13.17 | 13.60 | 12.58 |
PATM(%) | 8.32 | 8.16 | 8.09 | 8.34 | 8.55 | 7.95 |